İçeriğe geç
akaturk Akademik ölçüm
Giriş yap Kayıt ol

Akademisyen

CEM YAMALI

DOÇENT

ÇUKUROVA ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ TEMEL ECZACILIK BİLİMLERİ BÖLÜMÜ

Araştırma konuları OpenAlex
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Farmasotik Kimya
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 49
YÖKSİS49 OpenAlex0
Proje 13
Kitap 2
Bildiri 28

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 46
h-indeks 23 Türkiye yüzdelik dilimi: 98 Üniversitesinde h-indekse göre 30. / 1.449
i10-indeks
29
Toplam atıf
1.500
Türkiye’de üst %2,5
Makale başına
32,6
FWCI
2,38
1,00 = dünya ortalaması
Dünyada üst %1
0
Dünyada üst %10
18

En çok atıf alan makaleleri

  1. New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors 2018 dünyada üst %10 147 atıf
  2. Synthesis, molecular modeling, and biological evaluation of 4-[5-aryl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl] benzenesulfonamides toward acetylcholinesterase, carbonic anhydrase I and II enzyme 2018 dünyada üst %10 146 atıf
  3. Inhibitory effects of isatin Mannich bases on carbonic anhydrases acetylcholinesterase and butyrylcholinesterase 2016 dünyada üst %10 143 atıf

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 47
  • Q1 11 %23,4
  • Q2 23 %48,9
  • Q3 8 %17,0
  • Q4 5 %10,6
WoS (JCR) 44
  • Q1 21 %47,7
  • Q2 5 %11,4
  • Q3 10 %22,7
  • Q4 8 %18,2
TR Index 3 makale
OpenAlex atıf yüzdelik
Üst %10
Üst %1018
Ort. · n 46 %75,4
Diğer sayımlar

Scopus (SJR)

  • YÖKSİS satırı 47

WoS (JCR)

  • YÖKSİS satırı 44

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

49makale

Yayını olan dergiler

26 dergi

Daralt

Scopus (SJR)
Q111 Q223 Q38 Q45
WoS (JCR)
Q121 Q25 Q310 Q48
TR Index
3makale

Makale listesi

  1. 2026 Design, synthesis and QSAR-based antitumor signaling pathway analysis of pyrazoline- benzenesulfonamides mediated by cytostatic G1 arrest Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.143792 YÖKSİS SJR Q2 JCR Q2 OpenAlex 10.9%
  2. 2026 Potential of Time Domain Nuclear Magnetic Resonance as a Noninvasive Method for Detection and Quantification of Protein Glycation in Biopharmaceuticals Analytical Chemistry DOI 10.1021/acs.analchem.5c07921 YÖKSİS SJR Q1 JCR Q1 OpenAlex 14.6%
  3. 2026 Indole‐Chalcone‐Sulfonamide Hybrids: Synthesis and Dual Biological Evaluation as Anticancer and Antioxidant Agents Chemistry Select DOI 10.1002/slct.202503713 YÖKSİS SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 96.4%
  4. 2025 Synthesis, Bioactivities, and in Silico Studies of Novel Benzo[d][1,3]Dioxole-Based Pyrazoline Sulfonamides Polycyclic Aromatic Compounds DOI 10.1080/10406638.2025.2498144 YÖKSİS SJR Q3 JCR Q2 OpenAlex 76.5%
  5. 2025 Pharmaceutical Studies on Piperazine-based Compounds Targeting Serotonin Receptors and Serotonin Reuptake Transporters Mini-Reviews in Medicinal Chemistry DOI 10.2174/0113895575319878240612070850 YÖKSİS SJR Q2 JCR Q2 OpenAlex 77.7%
  6. 2025 Non-invasive detection of protein aggregation in biopharmaceuticals using TD-NMR and MRI European Journal of Pharmaceutics and Biopharmaceutics DOI 10.1016/j.ejpb.2025.114830 YÖKSİS SJR Q1 JCR Q1 OpenAlex 66.8%
  7. 2024 In Vitro Enzyme Activity and Molecular Docking Studies of Pyrazoline Derivatives as Monoamine Oxidase Inhibitors Pharmaceutical Chemistry Journal DOI 10.1007/s11094-024-03161-7 YÖKSİS SJR Q4 JCR Q4 OpenAlex 42.0%
  8. 2024 Biological Activities and Drug-Likeness Properties of Phenol-Based Heterocyclic Compounds Pharmaceutical Chemistry Journal DOI 10.1007/s11094-024-03076-3 YÖKSİS SJR Q4 JCR Q4 OpenAlex 71.9%
  9. 2024 Design, synthesis, biological evaluation and docking analysis of pyrrolidine-benzenesulfonamides as carbonic anhydrase or acetylcholinesterase inhibitors and antimicrobial agents Journal of Biomolecular Structure and Dynamics DOI 10.1080/07391102.2023.2214224 YÖKSİS SJR Q2 JCR Q3 OpenAlex 87.3%
  10. 2024 Synergistic quantification of mixed insulin preparations using time domain NMR techniques Journal of Pharmaceutical and Biomedical Analysis DOI 10.1016/j.jpba.2024.116260 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 91.5%
  11. 2023 Design, synthesis, and assessment of pharmacological properties of indole-based fluorinated chalcones and their benzenesulfonamide analogs CHEMICAL PAPERS DOI 10.1007/s11696-023-03060-3 YÖKSİS SJR Q2 JCR Q3 OpenAlex 80.4%
  12. 2023 Recent developments in tacrine-based hybrids as a therapeutic option for Alzheimer’s disease Mini-Reviews in Medicinal Chemistry DOI 10.2174/1389557523666221201145141 YÖKSİS SJR Q2 JCR Q3 OpenAlex 76.5%
  13. 2023 N-Benzoylthiourea-pyrrolidine carboxylic acid derivatives bearing an imidazole moiety: Synthesis, characterization, crystal structure, in vitro ChEs inhibition, and antituberculosis, antibacterial, antifungal studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2022.134303 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 90.4%
  14. 2023 Current Pharmaceutical Research on the Significant Pharmacophore Mannich bases in Drug Design Bentham Science Publishers Ltd. DOI 10.2174/0115680266256102230922101939 YÖKSİS SJR Q2 JCR Q3 OpenAlex 76.9%
  15. 2023 IMIDAZOLINONE-BASED SULFONAMIDE DERIVATIVES: SYNTHESIS, CHARACTERIZATION, AND INHIBITORY PROPERTY AGAINST SOME METABOLIC ENZYMES Ankara Universitesi Eczacilik Fakultesi Dergisi DOI 10.33483/jfpau.1311157 YÖKSİS SJR Q3 OpenAlex 39.2%
  16. 2023 Molecular docking studies and biological activities of benzenesulfonamide-based thiourea and thiazolidinone derivatives targeting cholinesterases, α-glucosidase, and α-amylase enzymes The Turkish Chemical Society DOI 10.18596/jotcsa.1111172 YÖKSİS OpenAlex 72.2%
  17. 2022 Quinazolinone-based benzenesulfonamides with low toxicity and high affinity as monoamine oxidase-A inhibitors: Synthesis, biological evaluation and induced-fit docking studies Bioorganic Chemistry DOI 10.1016/j.bioorg.2022.105822 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 97.4%
  18. 2022 Investigation of carbonic anhydrase inhibitory effects and cytotoxicities of pyrazole-based hybrids carrying hydrazone and zinc-binding benzenesulfonamide pharmacophores Bioorganic Chemistry DOI 10.1016/j.bioorg.2022.105969 YÖKSİS SJR Q1 JCR Q1 OpenAlex 82.8%
  19. 2021 Effects of a Novel Benzenesulfonamide 4-(3-(4-Bromophenyl)-5-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl) on Antioxidant Enzymes and Hematological Parameters of Rainbow Trout (Oncorhynchus mykiss) Pakistan Journal of Zoology DOI 10.17582/journal.pjz/20191118081134 YÖKSİS SJR Q4 JCR Q4 OpenAlex 46.0%
  20. 2021 Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides European Journal of Medicinal Chemistry DOI 10.1016/j.ejmech.2021.113351 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.7%

← Akademisyenlere dön